Improvement in Insulin Sensitivity and B-Cell Function Following Ileal Interposition with Sleeve Gastrectomy in Type 2 Diabetic Patients: Potential Mechanisms

Journal of Gastrointestinal Surgery

Volumn 15, Issue 8, 2011, Pages 1344-1353

  De Paula, Aureo Ludovico ^a   Stival, Alessandro R ^a   Halpern, Alfredo ^c   DePaula, Carolina C L ^e   Mari, Andrea ^d   Muscelli, Elza ^b   Vencio, Sergio ^e   Ferrannini, Ele ^b  

^a HOSPITAL DE ESPECIALIDADES   (Brazil)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CNR   (Italy)

^e PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

Author keywords

cell function; Diabetes; Ileal interposition; Insulin secretion; Insulin sensitivity; Metabolic surgery; Sleeve gastrectomy

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ARTICLE; BARIATRIC SURGERY; BLOOD; BODY MASS; FEMALE; GASTRECTOMY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; ILEUM; INSULIN RESISTANCE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ILEUM; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT;

EID: 79960847403     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1550-6     Document Type: Article

References (32)

1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. (2009) Weight and T2DM after bariatric surgery: systematic review and meta-analysis. Am J Med 122: 248-256.
2. Adams T, Gress R, Smith S, Halverson C, Simper S, Rosamond W, LaMonte M, Stroup A, Hunt S. (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 23: 357: 753-61.
3. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142(4): 621-32.
4. Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with T2DM mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281: 2005-12.
5. Ferrannini E, Mingrone G (2009) Impact of different bariatric surgical procedures on insulin action and beta-cell function in T2DM. Diabetes Care 32: 514-20.
6. Crookes PF. Surgical treatment of morbid obesity (2006) Annu Rev Med 57: 243-64.
7. Flancbaum L (1999) Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg 9: 516-23.
8. Dixon JB, O'Brien PE, Playfair J Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. (2008) Adjustable gastric banding and conventional therapy for T2DM: a randomized controlled trial. JAMA 299: 316-23.
9. DePaula AL, Macedo ALV, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern H. (2008) Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22: 706-16.
10. De Paula, AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008; 22: 2670-8.
11. American Diabetes Association (1997) Report of Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
12. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24: 539-48.
13. Mari A, Pacini G, Brazzale AR, Ahrén B (2005) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia 48: 748-51.
14. Mari A, Schmitz O, Gastaldelli A Oestergaard T, Nyholm B, Ferrannini E. (2002) Meal and oral glucose tests for assessment of β-cell action: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283: E1159-E1166.
15. Mari A, Camastra S, Toschi E Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E. (2001) A model for glucose control of insulin secretion during 24 h of free living. Diabetes 50: S164-8.
16. Schauer P (2005) 2004 ABS Consensus Conference: Gastric bypass for severe obesity: approaches and outcomes. Surg Obes Relat Dis 1: 297-30.
17. 2. Obes Surg 17: 185-92.
18. Frezza EE, Wozniak SE, Gee L, Wacthel M (2009) Is there any role of resecting the stomach to ameliorate weight loss and sugar control in morbidly obese diabetic patients? Obes Surg 19: 1139-42.
19. Weng J, Li Y, Xu W et al (2008) Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed T2DM: a multicenter randomised parallel-group trial. Lancet 371: 1753-60.
20. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90: 493-500.
21. Ferrannini E, Balkau B, Coppack SW Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H; RISC Investigators. (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92: 2885-9.
22. Walker M, Mari A, Jayapaul MK, Bennett SM, Ferrannini E (2005) Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia 48: 2470-6. Erratum in: Diabetologia (2006) 49: 1456.
23. Rossetti L, Giaccari A, DeFronzo RA (1990) Glucose toxicity. Diabetes Care; 13: 610-30.
24. DePaula AL, Macedo AL, Schraibman V, Mota BR, Vencio S. (2009) Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc 23: 1724-32.
25. Vestergaard ET, Gormsen LC, Jessen N (2008) Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 57: 3205-10.
26. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-39.
27. Muscelli E, Mari A, Casolaro A, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E. (2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57: 1340-8.
28. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. (2008) Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with T2DM. J Clin Endocrinol Metab 93: 2479-8.
29. Guidone C, Manco M, Valera-Mora E Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G. (2006) Mechanisms of recovery from T2DM after malabsorptive bariatric surgery. Diabetes 55: 2025-31.
30. Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ (2007) Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 3: 109-15.
31. DePaula AL, Stival AS, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m2. Surg Obes Relat Dis 2010; 6: 296-305.
32. Strader AD, Clausen TR, Goodin SZ, Wendt D (2009) Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats. Obes Surg; 19 96-104.